BITTER

COVID Science: Symptoms linger two years for some;  inflammatory protein patterns may provide long COVID clues

COVID Science: Symptoms linger two years for some; inflammatory protein patterns may provide long COVID clues

A medical worker prepares a syringe with a dose of the Johnson & Johnson coronavirus disease (COVID-19) vaccine during a visit of US Vice President Kamala Harris to a vaccination center in Chinatown, in Chicago, Illinois, US, April 6, 2021. Picture taken April 6, 2021. REUTERS/Carlos Barria Register now for FREE unlimited access to Reuters.com …

COVID Science: Symptoms linger two years for some; inflammatory protein patterns may provide long COVID clues Read More »

Black hole hunters cast gaze at center of the Milky Way galaxy

Black hole hunters cast gaze at center of the Milky Way galaxy

WASHINGTON, May 10 (Reuters) – Residing at the center of our spiral-shaped Milky Way galaxy is a beast – a supermassive black hole possessing 4 million times the mass of our sun and consuming any material including gas, dust and stars straying within its huge gravitational pull. Scientists have been using the Event Horizon Telescope …

Black hole hunters cast gaze at center of the Milky Way galaxy Read More »

Trump's $10,000-a-day fine for ignoring subpoena kicks in -NY judge

Trump’s $10,000-a-day fine for ignoring subpoena kicks in -NY judge

Former US President Donald Trump speaks during a rally to boost Ohio Republican candidates ahead of their May 3 primary election, at the county fairgrounds in Delaware, Ohio, US April 23, 2022. REUTERS/Gaelen Morse/File Photo/File Photo Register now for FREE unlimited access to Reuters.com Register NEW YORK, April 26 (Reuters) – Former President Donald Trump …

Trump’s $10,000-a-day fine for ignoring subpoena kicks in -NY judge Read More »

The case for testing Pfizer's Paxlovid for treating long COVID

The case for testing Pfizer’s Paxlovid for treating long COVID

Two long COVID patients recover after Paxlovid treatment Side effects, safety issues need to be studied CHICAGO, April 18 (Reuters) – Reports of two patients who found relief from long COVID after taking Pfizer Inc’s (PFE.N) antiviral Paxlovid, including a researcher who tested it on herself, provide intriguing evidence for clinical trials to help those …

The case for testing Pfizer’s Paxlovid for treating long COVID Read More »